Searched for
NORTH AMERICA PHARMA
ETMarkets PMS Talk | We analyse over 300 data points to identify alpha: Wright PMS' Sonam SrivastavaWright PMS's Sonam Srivastava champions a data-driven approach to active investing, analyzing over 300 data points to identify alpha. Her f...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Dr Reddy's shares in focus after Q4 net profit tumbles 86% YoY; Morgan Stanley, Goldman Sachs weigh inDr. Reddy's Laboratories shares: The pharma major posted a sharp 86% YoY drop in Q4FY26 consolidated net profit to Rs 221 crore, compared w...
- Pharma exports fall to five-year low in March amid West Asia crisisIndia's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...
- Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...
- Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the BoardSun Pharmaceutical Industries has appointed Kirti Ganorkar as Managing Director, succeeding Dilip Shanghvi, effective September 1. Shanghvi...
- Sun Pharma to buy remaining 21.5% in Taro for Rs 2,892 crSun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,8...
- Glenmark Pharma reports 31% drop in net profit to Rs 211 croreGlenmark is ranked 14th with a market share of 2.17% Sales from North America fell 10.2% YoY to Rs 663 crore. Europe sales saw 8% YoY to Rs...
- Pharma exports to cross USD 19 bn in FY19: PharmexcilPharma exports fetched USD 17.27 billion in the previous fiscal and this year it was expected to be between USD 19 billion and USD 20 billi...
- India launches flagship program to boost biopharma productionThe ministry, which has received a loan of $125 million (over Rs 800 crore) from the World Bank for its “Innovate in India” (i3) program, h...
- Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...
- Sun Pharma appoints Abhay Gandhi CEO of North American businessSun Pharma today announced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North America...
- Dr Reddy's leads the pecking order; expect stock to climb to Rs 4,000 level: Daljeet Singh KohliSun Pharma, Lupin have fallen in the pecking order just because they have not performed this quarter. But It does not mean that their outlo...
- Natco Pharma's partner Mylan Inc files ANDA for generic CopaxoneAccording to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
- Formulation sales drive Natco Pharma’s net profit up 43 per centWhile the Hyderabad based company's formulations sales grew to Rs 387 crore from Rs 294 crore, the bulk drug sales were down to Rs 221 cror...
- What does Crofelemer approval mean for Glenmark?What does Crofelemer approval mean for Glenmark?
- Pharma exports grew over 23 per cent in 2011-12: PharmexcilIndian pharma exports grew by 23.34 per cent in the last fiscal, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said.
- Fresenius to invest 30 mn euro in DaburFresenius Kabi, which acquired Dabur Pharma, is looking to expand the latter's oncology business globally with plans of investing up to 30 ...
Load More
